Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-03-18Clinical Trial Update: Study to Help Understand the Action of the Drug Etanercept for the Adult Patient With Psoriasis [Phase 3]
Phase 3 study to understand the action of etanercept in adults with psoriasis. The trial status is COMPLETED.
-
CLINICAL_TRIALS trial_result · 2011-03-16Clinical Trial Update: Efficacy of Two Algae Formulations on Lipid Metabolism, Inflammation and Oxidative Stress Status in Individuals With Psoriasis [Phase 1]
Phase 1 trial evaluating two algae formulations in psoriasis has completed, examining effects on lipid metabolism, inflammation, and oxidati…
-
CLINICAL_TRIALS trial_result · 2011-02-24Clinical Trial Update: A Study to Evaluate the Switch From Etanercept to Infliximab in Subjects With Moderate-to-Severe Psoriasis (Study P05133) [Phase 4]
Phase 4 trial evaluating switching from etanercept to infliximab in moderate-to-severe psoriasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2011-02-23Clinical Trial Update: Study to Evaluate the Efficacy of Infliximab Induction Therapy for Patients With Palmoplantar Psoriasis (PPP)(Study P04555)(COMPLETED) [Phase 3]
This completed Phase 3 trial evaluated the efficacy of infliximab induction therapy in patients with psoriasis, with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-02-23Clinical Trial Update: Pioglitazone in Psoriasis- A Clinical and Molecular Study. [NA]
A completed clinical trial assessing pioglitazone for psoriasis, including clinical and molecular study components.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-02-10Clinical Trial Update: CT 327 in the Treatment of Psoriasis Vulgaris [Phase 2]
A Phase 2 clinical trial of CT 327 for psoriasis vulgaris has completed, sponsored by Creabilis SA. The snippet does not include trial resul…
-
EMA withdrawal · 2011-01-31EMA Application withdrawn: Ozespa (briakinumab) — Abbott Laboratories Ltd.
The EMA withdrew the application for Ozespa (briakinumab) by Abbott Laboratories Ltd. for psoriasis.
-
FDA label_change · 2011-01-12FDA Approved: CLOBEX — Supplemental Application (Galderma Laboratories, L.P.)
FDA approved a supplemental labeling change for Clobex (clobetasol propionate) by Galderma Laboratories.
-
CLINICAL_TRIALS trial_result · 2010-12-24Clinical Trial Update: A Study to Evaluate Infliximab in Subjects With Moderate-to-Severe Psoriasis Not Responding to Standard or Biologic Therapy (Study P04612) [Phase 3]
This clinical trial update reports results from a Phase 3 study of infliximab in adults with moderate-to-severe psoriasis not responding to …
-
CLINICAL_TRIALS trial_result · 2010-12-23Clinical Trial Update: Double-blind, Randomized, Placebo-controlled Phase 3 Study of Etanercept in the Treatment of Psoriatic Arthritis and Psoriasis [Phase 3]
Phase 3 double-blind, randomized, placebo-controlled trial of etanercept for psoriatic arthritis and psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2010-12-22Clinical Trial Update: Fluphenazine Decanoate for Psoriasis [Phase 2]
A Phase 2 trial of fluphenazine decanoate for psoriasis was terminated, with results posted in December 2010.
-
CLINICAL_TRIALS trial_result · 2010-12-21Clinical Trial Update: Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment Compared With Tacalcitol Ointment in Patients With Psoriasis on the Face and Skin Folds [Phase 3]
Phase 3 trial comparing calcipotriol plus hydrocortisone ointment with tacalcitol ointment for psoriasis on the face and skin folds, assessi…
-
CLINICAL_TRIALS trial_result · 2010-12-13Clinical Trial Update: Evaluation of Clinical Outcomes in an Online Teledermatology Model for the Management of Psoriasis [Phase 2]
Phase 2 clinical trial evaluating outcomes of an online teledermatology model for managing psoriasis.
-
CLINICAL_TRIALS trial_result · 2010-12-08Clinical Trial Update: Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies [Phase 3]
This clinical trial update reports results from a Phase 3 study comparing the investigational agent U0267 to vehicle in plaque-type psoriasi…
-
CLINICAL_TRIALS trial_result · 2010-12-08Clinical Trial Update: Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis Two of Two Phase 3 Studies [Phase 3]
Two Phase 3 studies evaluating U0267 against vehicle in plaque-type psoriasis have completed, with results posted in December 2010.
-
CLINICAL_TRIALS trial_result · 2010-11-22Clinical Trial Update: Study Evaluating Management of Patients With Moderate and Severe Psoriasis
A clinical trial evaluating management of patients with moderate to severe psoriasis has completed; Wyeth is now a wholly owned subsidiary o…
-
CLINICAL_TRIALS trial_result · 2010-11-19Clinical Trial Update: Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]
Phase 3 trial results evaluate the efficacy and safety of adalimumab in adults with moderate to severe chronic plaque psoriasis. The study i…
-
CLINICAL_TRIALS trial_result · 2010-11-19Clinical Trial Update: Long-Term Effects of Infliximab in the Treatment of Moderate to Severe Psoriasis [Extension of Study P04271, NCT00251641] (P04563) [Phase 3]
Phase 3 extension study assesses long-term effects of infliximab in moderate-to-severe psoriasis; results were posted in 2010 and the study …
-
CLINICAL_TRIALS research · 2010-11-09Clinical Trial Update: Evaluation of Lymphocytic Infiltrate, Dendritic Cells and Cytokines Expression in Psoriatic Lesion and Normal Skin Before and After TNF Alfa Inhibitors Therapy [Phase 4]
Phase 4 clinical trial update evaluating lymphocytic infiltration, dendritic cells, and cytokine expression in psoriatic skin before and aft…
-
CLINICAL_TRIALS trial_result · 2010-11-01Clinical Trial Update: Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Hands and/or Feet [Phase 4]
Abbott's Humira (adalimumab) completed a Phase 4, controlled trial in chronic plaque psoriasis of the hands and/or feet, with results posted…
-
CLINICAL_TRIALS trial_result · 2010-10-27Clinical Trial Update: Efficacy Study of the Combination Mometasone + Salicylic Acid in Patients With Psoriasis [Phase 3]
A Phase 3 clinical trial evaluating the efficacy of a combination of mometasone furoate and salicylic acid for psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2010-10-19Clinical Trial Update: Sensitivity and Specificity of QuantiFeron -TB Gold Test (QFT-G)in Patients With Psoriasis [Phase 4]
Phase 4 clinical trial evaluating the sensitivity and specificity of the QuantiFERON-TB Gold interferon-gamma release assay in patients with…
-
FDA approval · 2010-10-06FDA Approved: CALCIPOTRIENE — Original Application (Mayne Pharma)
FDA approved the original application for CALCIPOTRIENE from Mayne Pharma. It is a topical vitamin D analog indicated for plaque psoriasis.
-
CLINICAL_TRIALS trial_result · 2010-09-02Clinical Trial Update: Effectiveness and Safety of Topical Halobetasol Propionate in the Treatment of Patients With Psoriasis [Phase 2, Phase 3]
This clinical trial update reports on the effectiveness and safety of topical halobetasol propionate for psoriasis in Phase 2 and Phase 3 tr…
-
CLINICAL_TRIALS trial_result · 2010-08-25Clinical Trial Update: Dose Ranging Study to Compare the Efficacy and Safety of Methotrexate in Plaque Type Psoriasis [Phase 4]
A Phase 4 dose-ranging clinical trial evaluating the efficacy and safety of methotrexate for plaque psoriasis has completed.